Overview of five Nordic countries: surgery for gender dysphoria remains reserved almost everywhere for adults

How strict are the Nordic countries when it comes to surgical and hormonal treatments for gender dysphoria? A group of eleven doctors and surgeons from Sweden, Denmark, Norway, Finland and Iceland examined this question jointly for the first time. Their overview article, published in the Scandinavian Journal of Surgery, compares the legislation, guidelines and clinical practice of all five countries — and reveals a striking pattern, precisely because these countries are often portrayed internationally as pioneers in gender-affirming care.

Surgery: almost everywhere only from the age of eighteen

The clearest pattern in the overview concerns surgery. In Finland and Iceland, breast, genital and facial surgery for gender dysphoria is in practice only available from the age of eighteen. Norway has no statutory ban on minors undergoing these procedures, but in practice does not offer them to minors. Sweden is the only exception with a lower age limit: breast surgery is available from the age of sixteen, while genital surgery is also deferred until adulthood. In other words, of the five countries often mentioned together as examples of progressive policy, not one offers unrestricted access to surgical transition care for children.

Hormones: only from the age of twelve, and subject to strict conditions

For puberty blockers and cross-sex hormones, the age threshold is lower, but according to the authors the conditions are substantial. Treatment can begin no earlier than age twelve, and only when a series of criteria have been met: documented gender incongruence that began in early childhood, an increase in symptoms after the onset of puberty, the absence of severe psychiatric comorbidity, and demonstrable understanding by the young person of the consequences of medical transition. The latter two conditions are precisely the points that critics of the affirmative model — including the British Cass Review and Sweden’s SBU — have been highlighting for some time: comorbidity is not always thoroughly ruled out in practice, and fully informed consent is a difficult criterion to assess in a twelve-year-old.

From pioneer to policy shift

The authors explicitly place this policy in a historical context. Denmark was regarded in the 1950s as the birthplace of modern gender-affirming surgery. In recent years, however, this same region has initiated a more cautious and rigorously evaluated policy shift: Sweden tightened its guidelines after an evaluation by the health authority SBU in 2022, and Finland did so as early as 2020 following advice from COHERE. Both countries concluded that the evidence for the effectiveness of medical transition care for minors was too weak to justify the existing, more permissive policy — and shifted to a more cautious model in which psychiatric care and long-term support take precedence over a rapid medical pathway.

More flexible with identity documents, stricter in the operating room

What stands out is the opposite movement in the legal sphere. Denmark, Finland, Iceland and Norway have switched to self-identification for legal gender registration, without medical or psychiatric requirements. Sweden eased its law on 1 July 2025: changes can be made from the age of sixteen, but a statement from a doctor, psychologist or other designated healthcare provider is still required, and the Socialstyrelsen decides on the application. Sweden therefore does not have full self-identification. The five countries thus show that flexible legal recognition of gender can readily coexist with — and remain separate from — strict medical criteria for those who actually receive hormones or surgery. That distinction between passport and consulting room is precisely what is often lost in the Dutch and Belgian debate, when recognition of gender identity and access to irreversible medical interventions are treated as one and the same issue.

What this means beyond Scandinavia

This overview does not change the regulations in the Netherlands or Belgium, but it provides a useful benchmark for the debate. Countries that were regarded for decades as the most liberal in this area in practice reserve surgery everywhere — with one narrow Swedish exception — for adults, and introduce explicit safeguards for hormonal treatment of minors against rushed or insufficiently substantiated decisions. This calls for a sober view of what “progressive policy” actually means in practice: not fewer conditions, but a more carefully defined, age-based pathway. A related article discusses the differences in transgender care between the Nordic countries. A table showing policy by country, from permissive to cautious, is available at transwijzer.nl.